InvestSMART

Heartland Group Holdings Limited (ASX:HGH)

ALERT: Price-sensitive ASX Announcement for HGH
Current share price for HGH : $1.030 0.37 (56.06%)+
Announcement
Release
16 Apr 2025 7:31AM
Price at Release
$0.660
Full Release
download
Summary
Heartland Group Holdings Limited has released its trading update for the three months ending March 31, 2025, indicating a strong performance with a projected net profit after tax (NPAT) of at least $45 million for the financial year ending June 30, 2025. Key highlights include an improvement in net interest margin (NIM) by 28 basis points, stable operating expenses, and growth in Reverse Mortgages and Livestock Finance in both New Zealand and Australia. The company's initiatives in asset quality enhancement are showing positive trends, particularly in Motor Finance, while strategic cost management programs are expected to bolster operational efficiency moving forward.
Key Points
  • Projected NPAT for FY2025 of at least $45 million.
  • NIM expanded by 28 basis points in Q3.
  • Operating expenses remained stable.
  • Improvements in asset quality in Motor Finance portfolio.
  • Strong growth in Reverse Mortgages and Livestock Finance in both New Zealand and Australia.
  • Cost management programs are in place for operational efficiency.
  • Good progress on non-strategic asset realisation targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.